🔓
Sign in as a Member to unlock the full view of EQ. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$24.50/mo already a Member? Sign in →
EQ

Equillium, Inc.

Sector: healthcareBiotechnologyNASDAQMarket Cap: $61.8M

Equillium is a clinical-stage immunology company with minimal political/regulatory footprint and no measurable government dependence or lobbying activity.

Next filing → your inbox
Govt Dependence
5/100
Regulatory Density
35/100
Lobbying Intensity
0/100
Political Signal
NONE

BusinessWhat EQ does

Equillium develops cell therapy and immunology treatments, primarily focused on transplant rejection and autoimmune diseases. The company is pre-commercial or early-stage revenue, with R&D as primary expense driver and no significant government contracts or regulated reimbursement streams.

Lifetime Government AwardsEQ federal contracts

EQ doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

No Form 4 activity recorded in the last 180 days.

Bills Affecting EQLive legislation impacting this stock

Political ProfileWhere EQ sits in Washington

No lobbying activity, no politician trades, no campaign donations, and pre-commercial status mean political/regulatory news has minimal direct stock impact. Movement driven by clinical trial results and biotech sentiment, not policy.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • FDA approval delays
  • clinical trial recruitment challenges

Regulatory opportunities

  • Orphan drug designation
  • Breakthrough Therapy designation
  • accelerated FDA pathways
Member intelligence layer

Live signals + predictions for EQ — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $24.50/mo Locked rate forever · cancel anytime

Frequently AskedAbout EQ & political exposure

Does Equillium, Inc. (EQ) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Equillium, Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
What is EQ political risk profile?
Government dependence: 5/100. Lobbying intensity: 0/100. Political signal: none.
How does GovGreed track EQ political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. EQ data is updated daily from these official federal sources.